Skip to main content
. 2024 Nov 28;30(44):4725–4737. doi: 10.3748/wjg.v30.i44.4725

Figure 3.

Figure 3

The baseline. A: Hepatitis B surface antigen seroconversion rate; B: Hepatitis B surface antibody level in the different consolidation therapy groups. bP < 0.01. HBsAg: Hepatitis B surface antigen; HBsAb: Hepatitis B surface antibody.